Indicators of carbohydrate metabolism in rats with different levels of hepatic detoxification activity in experimental diabetes mellitus
Annotatsiya
Carbohydrate metabolism is a crucial factor in understanding the pathophysiology of diabetes. Variations in detoxification capacity among metabolic phenotypes, such as rapid, moderate, and slow metabolizers, may influence the progression of alloxan-induced diabetes and the associated glucose homeostasis, insulin secretion, and C-peptide levels. PURPOSE OF THE STUDY. This study aimed to evaluate features of carbohydrate metabolism during alloxan-induced diabetes in rats classified as rapid, moderate, and slow metabolizers. MATERIALS AND METHODS. The study included intact rats classified by metabolic phenotype according to hepatic detoxification activity. Alloxan was administered to induce diabetes, and blood glucose, insulin, and C-peptide concentrations were measured on days 7, 14, and 21. Values obtained before alloxan administration served as baseline. Glucose tolerance tests (GTTs) and area-under-the-curve (AUC) analyses were performed to assess glucose dynamics. RESULTS. By day 7 of the experiment, blood glucose levels increased by 149.7%, 120.5%, and 122.9% in rapid, moderate, and slow metabolizers, respectively, compared with baseline values. On day 14, these increases reached 186.8%, 149.3%, and 140.7%, whereas by day 21 they were 270.5%, 188.0%, and 176.2%, respectively. Rapid metabolizers exhibited the highest glucose levels and the largest decreases in insulin and C-peptide concentrations during the study. GTT results showed impaired glucose tolerance in all metabolic phenotypes by day 21, with rapid metabolizers showing the largest increase in AUC. CONCLUSION. This study identified significant differences in carbohydrate metabolism among metabolic phenotypes under conditions of alloxan-induced diabetes. Rapid metabolizers showed more pronounced hyperglycemia and lower insulin secretion than moderate and slow metabolizers. The findings support further investigation of individual metabolic characteristics when developing phenotype-specific strategies for diabetes management.
Hali tarjima qilinmagan